Please try another search
Barak Investment House Ltd provides pharmaceutical solutions for patients and physicians in Israel and internationally. It offers pharma-grade smokeless cannabis products, such as oral tablets, orodispersible tablets, sublingual tablets, oral oils, sublingual drops, solution for inhalation, pastilles, topicals, suppositories, and cannabis extracts in ethanol under the NAXIVA – PANAXOL, NAXIVA-PANAXOL-ONKO, PANAXIR SENSE, PANAXIR, Axiban, Tikva, Ultra Health, and Salus brands. The company was formerly known as Panaxia Labs Israel Ltd and changed its name to Barak Investment House Ltd in May 2024. Barak Investment House Ltd was incorporated in 2005 and is based in Lod, Israel.
Name | Age | Since | Title |
---|---|---|---|
Dedi Segal | 47 | - | Founder & CEO & Director |
Asi Rotbert | 48 | - | Chief Business Officer & Director |
Markus Veit | 65 | 2019 | Scientific Advisor |
David Meiri | - | - | Scientific Advisor |
Aaron Ciechanover | 77 | 2019 | Scientific Advisor |
Michal Sapir | 67 | 2022 | Independent External Director |
Rinat Gazit | 55 | - | Independent Director |
Deir Noa Leibovich | - | - | Scientific Advisor |
Moshe Reuveni | 68 | - | Independent External Director |
Michal Marom-Brikman | 55 | - | Independent External Director |
Tal Yaron Eldar | 61 | - | Director |
Michal Dadon-Yagil | 54 | - | Independent External Director |
Essie Rothbert | 49 | - | Chairman |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review